Mcgeevalenzuela9455
To determine the absolute and relative intra-rater within-session test-retest reliability of pressure pain threshold (PPT) and mechanical temporal summation of pain (TSP) at the low back and the forearm in healthy participants and to test the influence of the number and sequence of measurements on reliability metrics.
In 24 participants, three PPT and TSP measures were assessed at four sites (2 at the low back, 2 at the forearm) in two blocks of measurements separated by 20 minutes. The standard error of measurement, the minimal detectable change (MDC) and the intraclass correlation coefficient (ICC) were investigated for five different sequences of measurements (e.g. measurement 1, 1-2, 1-2-3).
The MDC for the group (MDCgr) for PPT ranged from 28.71 to 50.56 kPa across the sites tested, whereas MDCgr for TSP varied from 0.33 to 0.57 out of 10 (numeric scale). Almost all ICC showed an excellent relative reliability (between 0.80 and 0.97), except when only the first measurement was considered (moderate). Although minimal differences in absolute PPT reliability were present between the different sequences, in general, using only the first measurement increase measurement error. Three TSP measures reduced the measurement error.
We established that two measurements of PPT and three of TSP reduced the measurement error and demonstrated an excellent relative reliability. Our results could be used in future pain research to confirm the presence of true hypo/hyperalgesia for paradigms such as conditioned pain modulation or exercise-induced hypoalgesia, indicated by a change exceeding the measurement variability.
We established that two measurements of PPT and three of TSP reduced the measurement error and demonstrated an excellent relative reliability. Our results could be used in future pain research to confirm the presence of true hypo/hyperalgesia for paradigms such as conditioned pain modulation or exercise-induced hypoalgesia, indicated by a change exceeding the measurement variability.
In Japan, there is a large geographical maldistribution of obstetricians/gynecologists, with a high proportion of females. This study seeks to clarify how the increase in the proportion of female physicians affects the geographical maldistribution of obstetrics/gynecologists.
Governmental data of the Survey of Physicians, Dentists and Pharmacists between 1996 and 2016 were used. The Gini coefficient was used to measure the geographical maldistribution. We divided obstetricians/gynecologists into four groups based on age and gender males under 40 years, females under 40 years, males aged 40 years and above, and females aged 40 years and above, and the time trend of the maldistribution and contribution of each group was evaluated.
The maldistribution of obstetricians/gynecologists was found to be worse during the study period, with the Gini coefficient exceeding 0.400 in 2016. The contribution ratios of female physicians to the deterioration of geographical maldistribution have been increasing for those urved areas, such a notion needs to be investigated in a follow-up study.The main forms of poly-γ-glutamic acid (γ-PGA) applied in agriculture include agricultural γ-PGA and γ-PGA super absorbent polymer (SAP). Laboratory experiments were conducted with a check treatment CK (no γ-PGA added) and two different forms of γ-PGA added to sandy loam soil (T and TM stand for γ-PGA and γ-PGA SAP) at four different soil mass ratios (0.05% (1), 0.10% (2), 0.15% (3) and 0.20% (4)) to determine their effects on sandy loam soil hydro-physical properties. Both of them could reduce the cumulative infiltration of soil water. The total available water (TAW) which the soil water content (SWC) from field water capacity (FC) to permanent wilting point (PWP) after γ-PGA added into sandy loam soil had no significant different compared with CK, and the TAW was highest at the treatment of γ-PGA with 0.10% addition amount into sandy loam soil. However, the TAW of sandy loam soil increased dramatically with the γ-PGA SAP addition amount increasing. TM3 had the highest soil water absorption among the treatments with γ-PGA SAP. The T1 to T4 treatments with γ-PGA addition slightly prolonged retention time (RT) when SWC varied from FC to PWP compared with CK. For γ-PGA SAP addition treatments, the time for SWC varied from FC to PWP was 1.48 times (TM1), 1.88 times (TM2), 2.01 times (TM3) and 2.87 times (TM4) longer than that of CK, respectively. The results of this study will provide further information for the use of these materials in agricultural application.
Obstructive sleep apnea (OSA) is a frequent condition. In the absence of treatment, OSA is associated with a higher risk of traffic accidents and a large variety of diseases. Taurochenodeoxycholicacid The objectives of this study were to describe the characteristics of patients treated for OSA in France and assess the time trends in treatment.
The French National Health Data System is an individual database with data on all healthcare reimbursements for the entire French population. Based on this database, we included all patients aged 20 years or over who were treated with continuous positive airway pressure (CPAP) or mandibular advancement splint (MAS) between 2009 and 2018. Negative binomial models, adjusted for age, were used to assess time trends in treatment prevalence and incidence rates.
In 2017, 2.3% of French adults aged ≥20 years were treated with CPAP (men 3.3%; women 1.3%). The highest prevalence was observed in people aged 70-74 years (5.0%). From 2009 to 2018, the annual prevalence of CPAP increased 3-fold and the annual incidence 1.9-fold. During the same period, the rate of patients reimbursed for MAS (first prescription or renewal) was multiplied by 7.6. The proportion of patients treated with CPAP in 2017 who were no longer treated in the subsequent year was 6.9%.
The sharp increase in the incidence of OSA treatment probably reflects a better recognition of the disease in France. However, the prevalence of OSA treatment remains lower than expected based on the international literature. Further studies are needed to identify the obstacles to an optimal management of individuals with OSA in France.
The sharp increase in the incidence of OSA treatment probably reflects a better recognition of the disease in France. However, the prevalence of OSA treatment remains lower than expected based on the international literature. Further studies are needed to identify the obstacles to an optimal management of individuals with OSA in France.